Observational studyEuropean heart journal2016

XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.

A John Camm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.